Talk:Lisdexamfetamine

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
Stub	This article has been rated as Stub-class on Wikipedia's content assessment scale.
???	This article has not yet received a rating on the project's importance scale.

Vyvanse (Lisdeamphetamine) is known to have a much "smoother" onset and comedown than adderall and adderall xr, with a much longer effective dosage span ranging up to 12 hours. It is also thought to be less easy to abuse than adderall, ritalin, and dexedrine because it cannot effectively be snorted or used intravenously. It may only be ingested orally, as the lisene molecule is naturally stripped away by our digestive system, releasing the drug subsequently. Users may still abuse the drug by swallowing a higher dose than prescribed. —Preceding unsigned comment added by 76.90.53.237 (talk) 08:56, 16 October 2007 (UTC)[reply]

Lysdexic?

Why does the name of this drug make me think of "lysdexic amphetamine"? --Damian Yerrick (talk | stalk) 02:11, 20 February 2008 (UTC)[reply]

Bipolar depression... really?

I see someone has added that that Shire is going to apply to use this to treat bipolar, but bipolar is one of the things that usually ends up mentioned in a list of possible contraindications rather than treatable illnesses, so I am curious what the source is for this primarily because I'd really like to see if Shire has indeed addressed with this medication some of the shortcomings Dexedrine had when attempts were made in the distant past ("Why is this woman tired" ad campaign, etc) to use it for similar purposes. Zaphraud (talk) 04:17, 24 March 2008 (UTC)[reply]

Clarification There is no evidence that Shire has ever tried to apply Vyvanse to treat bipolar disorder —Preceding unsigned comment added by Slg278 (talk • contribs) 17:14, 4 May 2008 (UTC)[reply]

Look up the prescribing guides - Bipolar is a contradiction on every amphetamine-based medication. Amide10806 (talk) 09:01, 10 November 2008 (UTC)[reply]

Ages 13 to 17?

From the article: "Vyvanse is FDA approved for the treatment of attention-deficit hyperactivity disorder in pediatric patients ages 6–12, and in adults." I don't think that's entirely clear. Does this mean it isn't approved for ages 13 through 17? --Damian Yerrick (talk | stalk) 16:46, 28 June 2008 (UTC)[reply]